Financial comparisons Celltrion, Inc.

Equities

End-of-day quote Korea S.E. Other stock markets 21/04/2026			5-day change	1st Jan Change
203,000.00 ^KRW	-1.22%		+1.96%	+12.15%

06:16am	Celltrion to buy 100 billion won of own shares	RE
04-08	Nomura Adjusts Celltrion's Price Target to KRW270,000 From KRW240,000, Keeps at Buy	MT

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Revenues (N-1)	Net Margin (N-1)	EBIT Margin (N-1)	ROE (N-1)	ROA (N-1)	Leverage (N-1)
CELLTRION, INC.	2.88B	24.74%	28.07%	5.94%	4.75%	2.2x
LONZA GROUP AG	8.24B	14.53%	21.7%	10.28%	4.9%	1.58x
BEONE MEDICINES AG	5.34B	5.37%	8.37%	29.84%	16.27%	-5.99x
IQVIA HOLDINGS INC.	16.31B	8.34%	13.38%	32.9%	4.79%	3.63x
MEDPACE HOLDINGS, INC.	2.53B	17.83%	20.93%	70.23%	22.13%	-0.89x
EUROFINS SCIENTIFIC SE	8.57B	6.51%	14.79%	9.61%	4.34%	2.22x
IONIS PHARMACEUTICALS, INC.	944M	-40.36%	-40.47%	-70.72%	-11.67%	4.51x
TEMPUS AI, INC.	1.27B	-19.27%	-3.71%	-38.64%	-6.61%	-65.61x
BIO-TECHNE CORPORATION	1.22B	6.02%	31.45%	15.37%	11.65%	0.43x
ABIVAX	5.4M	-7,306.52%	-5,350%	-135.58%	-	2.1x
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	4.02B	-3.59%	19.77%	15.46%	6.99%	1.98x
ICON PUBLIC LIMITED COMPANY	8.28B	9.56%	19.29%	12.39%	6.87%	1.66x
QIAGEN N.V.	2.09B	20.33%	29.46%	17.5%	10.73%	0.74x
BLUEPRINT MEDICINES CORPORATION	509M	-13.19%	-41.67%	-31.26%	-21.6%	-0.14x
PHARMARON BEIJING CO., LTD.	2.02B	11.8%	13.68%	11.6%	6.52%	1.81x
KYMERA THERAPEUTICS, INC.	39.21M	-794.04%	-891.07%	-25.78%	-22.89%	4.75x
Average	4.02B	-503.25%	-381.63%	-4.43%	2.48%	-2.81x
Weighted average by Cap.	5.7B	-274.22%	-202.29%	5.82%	5.1%	-1.67x